CME Group stock gains as FedWatch anchors market attention

Published on 09/21/2026 at 13:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

CME Group stock drew attention on September 21, 2026, as Reuters said the FedWatch tool showed a 53 percent chance of another rate hike. Q2 2026 revenue was $1,706.2 million and diluted EPS was $2.88.

Fotorealistisches Bild eines modernen Derivate-Handelsraums mit Monitoren und Händlern — CME Group Inc. Handelsparkett mit Futures-Bildschirmen, ISIN US12572Q1058 repräsentiert den globalen Derivatemarkt, Illustration mit AI erstellt.

CME Group Inc. stock (ISIN US12572Q1058) was still tied to interest-rate expectations on September 21, 2026, with Reuters saying the CME Group FedWatch Tool showed a 53 percent chance of another rate hike next month.

Q2 revenue and EPS

For the second quarter of 2026, CME Group reported total revenue of $1,706.2 million, net income of $1,041.8 million and diluted EPS of $2.88, according to StockTitan. The filing summary said revenue was slightly above Q2 2025, while net income rose from $1,025.1 million a year earlier.

Half-year numbers

For the six months ended June 30, 2026, revenue reached $3,586.3 million and net income was $2,196.1 million, with diluted EPS at $6.06, also in the StockTitan summary. That compares with Q1 2026 revenue of $1,880.1 million, up 14 percent from $1,642.3 million a year earlier, and Q1 diluted EPS of $3.18, up from $2.62.

Price and chart level

CME Group stock traded at USD 265.00 as of September 21, 2026, with a market capitalization of USD 95.0 billion, a 52-week range of USD 225.00 to USD 290.00 and volume of 1.8 million shares. For investors, the key detail is that the stock sat about 8.6 percent below the 52-week high.